UK Stocks-Factors to watch on October 20 (updated)
UK Stocks-Factors to watch on October 20
AstraZeneca's Datroway extends survival in aggressive breast cancer
AstraZeneca's Enhertu shows promise in early-stage breast cancer treatment
Brief: Datroway Plus Rilvegostomig Showed Promising Tumor Responses In Tropion-Pantumor03 Phase 2 Trial
AstraZeneca and Daiichi's Datroway boosts overall survival in breast cancer trial (updated)
AstraZeneca's Datroway boosts survival in advanced breast cancer trial
Brief: AstraZeneca Says Datroway Safety Profile Consistent With Previous Trials
Brief: Enhertu® Followed Biologics License Application Accepted In The U.S. For Patients With Early-Stage Breast Cancer Prior To Surgery
Shares of Asian drugmakers drop after Trump threatens tariffs (updated)
Brief: EU Validates Enhertu Application for Previously Treated HER2-Positive Solid Tumors
BioNTech, Duality score initial trial win with breast cancer precision drug (updated)
Brief: Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation By U.S. FDA For Patients With Pretreated Extensive-Stage Small Cell Lung Cancer
Table: Daiichi Sankyo -Q1 group results (IFRS)
Travel stocks lift UK midcaps after Israel-Iran ceasefire (updated)
UK shares rise on Israel-Iran ceasefire relief
UK's AstraZeneca rises on US approval for Datroway to treat lung cancer
US approves AstraZeneca, Daiichi's treatment for lung cancer (updated)
UK Stocks-UK Factors to watch on June 24 (updated)